Yuichi Komine
Direktor/Vorstandsmitglied bei ONCOTHERAPY SCIENCE, INC.
Aktive Positionen von Yuichi Komine
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ONCOTHERAPY SCIENCE, INC. | Direktor/Vorstandsmitglied | 01.09.2014 | - |
Comptroller/Controller/Auditor | 01.06.2008 | 01.09.2014 | |
SUN-LIFE HOLDING CO.,LTD. | Direktor/Vorstandsmitglied | 01.10.2018 | - |
G&G Science Co., Ltd.
G&G Science Co., Ltd. Miscellaneous Commercial ServicesCommercial Services G&G Science Co., Ltd. provides research and development services for DNA analysis and consulting. The private company is based in Fukushima, Japan. | Comptroller/Controller/Auditor | 01.04.2005 | - |
Immunas Pharma, Inc.
Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | Direktor/Vorstandsmitglied | 01.02.2017 | - |
Sun Life Members Co., Ltd. | Comptroller/Controller/Auditor | 01.11.2011 | - |
Karriereverlauf von Yuichi Komine
Statistik
International
Japan | 6 |
Operativ
Comptroller/Controller/Auditor | 3 |
Director/Board Member | 3 |
Sektoral
Health Technology | 3 |
Commercial Services | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ONCOTHERAPY SCIENCE, INC. | Health Technology |
SUN-LIFE HOLDING CO.,LTD. | Consumer Services |
Private Unternehmen | 3 |
---|---|
G&G Science Co., Ltd.
G&G Science Co., Ltd. Miscellaneous Commercial ServicesCommercial Services G&G Science Co., Ltd. provides research and development services for DNA analysis and consulting. The private company is based in Fukushima, Japan. | Commercial Services |
Immunas Pharma, Inc.
Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | Health Technology |
Sun Life Members Co., Ltd. |
- Börse
- Insiders
- Yuichi Komine
- Erfahrung